vs
Side-by-side financial comparison of RH (RH) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
RH is the larger business by last-quarter revenue ($883.8M vs $622.0M, roughly 1.4× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 4.1%, a 30.3% gap on every dollar of revenue. On growth, RH posted the faster year-over-year revenue change (8.9% vs 4.8%). Over the past eight quarters, RH's revenue compounded faster (9.4% CAGR vs 4.6%).
RH is an upscale American home-furnishings company headquartered in Corte Madera, California. The company sells its merchandise through its retail stores, catalog, and online. As of August 2018, the company operated a total of 70 galleries, 18 full-line design galleries, and 3 baby-and-child galleries. The company also has 36 outlet stores in the United States and Canada.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
RH vs RPRX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $883.8M | $622.0M |
| Net Profit | $36.3M | $214.2M |
| Gross Margin | 44.1% | — |
| Operating Margin | 12.0% | 62.4% |
| Net Margin | 4.1% | 34.4% |
| Revenue YoY | 8.9% | 4.8% |
| Net Profit YoY | 9.3% | 2.9% |
| EPS (diluted) | $1.83 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $883.8M | $622.0M | ||
| Q3 25 | $899.2M | $609.3M | ||
| Q2 25 | $814.0M | $578.7M | ||
| Q1 25 | $812.4M | $568.2M | ||
| Q4 24 | $811.7M | $593.6M | ||
| Q3 24 | $829.7M | $564.7M | ||
| Q2 24 | $727.0M | $537.3M | ||
| Q1 24 | $738.3M | $568.0M |
| Q4 25 | $36.3M | $214.2M | ||
| Q3 25 | $51.7M | $288.2M | ||
| Q2 25 | $8.0M | $30.2M | ||
| Q1 25 | $13.9M | $238.3M | ||
| Q4 24 | $33.2M | $208.2M | ||
| Q3 24 | $29.0M | $544.0M | ||
| Q2 24 | $-3.6M | $102.0M | ||
| Q1 24 | $11.4M | $4.8M |
| Q4 25 | 44.1% | — | ||
| Q3 25 | 45.5% | — | ||
| Q2 25 | 43.7% | — | ||
| Q1 25 | 44.7% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 43.5% | — | ||
| Q1 24 | 43.5% | — |
| Q4 25 | 12.0% | 62.4% | ||
| Q3 25 | 14.3% | 70.1% | ||
| Q2 25 | 6.9% | 36.3% | ||
| Q1 25 | 8.7% | 94.0% | ||
| Q4 24 | 12.5% | 60.9% | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 7.5% | 50.2% | ||
| Q1 24 | 8.7% | -13.0% |
| Q4 25 | 4.1% | 34.4% | ||
| Q3 25 | 5.8% | 47.3% | ||
| Q2 25 | 1.0% | 5.2% | ||
| Q1 25 | 1.7% | 41.9% | ||
| Q4 24 | 4.1% | 35.1% | ||
| Q3 24 | 3.5% | 96.3% | ||
| Q2 24 | -0.5% | 19.0% | ||
| Q1 24 | 1.5% | 0.8% |
| Q4 25 | $1.83 | $0.49 | ||
| Q3 25 | $2.62 | $0.67 | ||
| Q2 25 | $0.40 | $0.07 | ||
| Q1 25 | $0.71 | $0.55 | ||
| Q4 24 | $1.66 | $0.46 | ||
| Q3 24 | $1.45 | $1.21 | ||
| Q2 24 | $-0.20 | $0.23 | ||
| Q1 24 | $0.91 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.1M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $3.3M | $9.7B |
| Total Assets | $4.8B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.1M | $618.7M | ||
| Q3 25 | $34.6M | $938.9M | ||
| Q2 25 | $46.1M | $631.9M | ||
| Q1 25 | $30.4M | $1.1B | ||
| Q4 24 | $87.0M | $929.0M | ||
| Q3 24 | $78.3M | $950.1M | ||
| Q2 24 | $101.8M | $1.8B | ||
| Q1 24 | $123.7M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $3.3M | $9.7B | ||
| Q3 25 | $-40.9M | $9.6B | ||
| Q2 25 | $-110.8M | $9.5B | ||
| Q1 25 | $-163.6M | $9.8B | ||
| Q4 24 | $-183.0M | $10.3B | ||
| Q3 24 | $-234.7M | $10.3B | ||
| Q2 24 | $-289.9M | $9.8B | ||
| Q1 24 | $-297.4M | $9.9B |
| Q4 25 | $4.8B | $19.6B | ||
| Q3 25 | $4.7B | $19.3B | ||
| Q2 25 | $4.7B | $18.3B | ||
| Q1 25 | $4.6B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.4B | $18.0B | ||
| Q2 24 | $4.2B | $17.7B | ||
| Q1 24 | $4.1B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.9M | $827.1M |
| Free Cash FlowOCF − Capex | $83.0M | — |
| FCF MarginFCF / Revenue | 9.4% | — |
| Capex IntensityCapex / Revenue | 5.5% | — |
| Cash ConversionOCF / Net Profit | 3.64× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $128.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $131.9M | $827.1M | ||
| Q3 25 | $137.7M | $702.6M | ||
| Q2 25 | $86.6M | $364.0M | ||
| Q1 25 | $-18.8M | $596.1M | ||
| Q4 24 | $-31.4M | $742.5M | ||
| Q3 24 | $11.2M | $703.6M | ||
| Q2 24 | $56.1M | $658.2M | ||
| Q1 24 | $-114.0M | $664.6M |
| Q4 25 | $83.0M | — | ||
| Q3 25 | $80.7M | — | ||
| Q2 25 | $34.1M | — | ||
| Q1 25 | $-69.7M | — | ||
| Q4 24 | $-96.0M | — | ||
| Q3 24 | $-37.9M | — | ||
| Q2 24 | $-10.1M | — | ||
| Q1 24 | $-251.5M | — |
| Q4 25 | 9.4% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | -11.8% | — | ||
| Q3 24 | -4.6% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -34.1% | — |
| Q4 25 | 5.5% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 6.3% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 18.6% | — |
| Q4 25 | 3.64× | 3.86× | ||
| Q3 25 | 2.66× | 2.44× | ||
| Q2 25 | 10.78× | 12.06× | ||
| Q1 25 | -1.35× | 2.50× | ||
| Q4 24 | -0.95× | 3.57× | ||
| Q3 24 | 0.39× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | -10.01× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RH
| RH Segment | $835.8M | 95% |
| Waterworks Segment | $48.0M | 5% |
| Gift Card And Merchandise Credit | $4.5M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
